Glenmark Pharmaceuticals introduces Fingolimod Capsules in US
India-based Glenmark Pharmaceuticals said that its subsidiary Glenmark Pharmaceuticals Inc., USA has introduced its Fingolimod Capsules, 0.5 mg in the US market. The product is ... Read More
Glenmark Pharmaceuticals launches Rufinamide Tablets in US
Glenmark Pharmaceuticals said that it has launched Rufinamide Tablets USP, 200 mg and 400 mg in the US, which is a therapeutic equivalent of Banzel ... Read More